Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer

Targeting EGFR, epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs), brings lights to the treatment of non-small cell lung cancer (NSCLC). Although T790M mutation responded as one of the main reasons of acquired resistance, still 15% of the resistance patients can't be expla...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangda, Ma, Yunfei, Yu, Mingwei, Li, Xiaoxiao, Chen, Xinjie, Gao, Yu, Cheng, Peiyu, Zhang, Ganlin, Wang, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317531/
https://www.ncbi.nlm.nih.gov/pubmed/34335945
http://dx.doi.org/10.7150/jca.56506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317531/
https://www.ncbi.nlm.nih.gov/pubmed/34335945
http://dx.doi.org/10.7150/jca.56506

Ejemplares similares